Best Doctors for Chemotherapy in India

Dr. Lalit Kumar is the Chairperson of Oncology & Bone Marrow Transplant at Artemis Hospital in Gurgaon, bringing over four decades of distinguished experience in hematologic oncology, stem cell transplantation, and medical oncology. Recipient of the prestigious Padma Shri Award in 2014, one of India's highest civilian honors, Dr. Kumar has made extraordinary contributions to advancing cancer care and transplant medicine. His academic credentials include an MBBS and MD from Sarojini Naidu Medical College, Agra, and a DM in Medical Oncology from Adyar Cancer Institute, Chennai, complemented by postdoctoral training at the Royal Postgraduate Medical School of Hammersmith Hospital, London, and a Fulbright Scholarship from the United States. Dr. Kumar's clinical expertise spans the full spectrum of hematologic malignancies and solid tumor oncology. He specializes in bone marrow and stem cell transplantation—both allogeneic and autologous—with particular proficiency in treating multiple myeloma, lymphoma, acute leukemia, and chronic leukemia. His work in neoadjuvant chemotherapy and targeted immunotherapy for advanced cancers has established him as a leading voice in the field. He is widely recognized for developing cost-effective treatment protocols that have made life-saving transplant procedures more accessible without compromising clinical outcomes. Prior to his current role, Dr. Kumar served as Professor and Head of the Department of Medical Oncology at AIIMS, New Delhi, where he consolidated his reputation as an educator and researcher. International patients from the Gulf region, Africa, and South Asia seek Dr. Kumar's care for complex hematologic and oncologic conditions. He has a proven track record managing cases referred from diverse geographic backgrounds and maintains a patient-centered approach that prioritizes compassionate communication and tailored treatment planning. His involvement with the Indo-British Health Initiative and memberships in the Institute of Women's Health (UCL) further reflect his commitment to advancing global oncology standards. Artemis Hospital, where Dr. Kumar leads the oncology and transplant division, is a premier multispecialty facility equipped with state-of-the-art diagnostic and therapeutic infrastructure. The hospital maintains rigorous quality standards and supports a robust international patient services desk, making it an ideal destination for overseas patients seeking specialized cancer and transplant care. For international patients considering bone marrow or stem cell transplantation, or seeking second opinions on complex hematologic and solid tumor cases, Artemis Hospital offers both world-class clinical expertise and a comprehensive support ecosystem to ensure smooth treatment and recovery.

Dr. Rupinder Sekhon is a senior consultant in gynaecologic oncology and surgical oncology, bringing over 35 years of distinguished clinical expertise to the management of women's cancers. She holds MBBS and MD qualifications in Obstetrics & Gynaecology and is certified as a Robotic Console Surgeon since 2011. Recognised as one of India's leading gynaecologic oncologists, Dr. Sekhon has established herself as a specialist in the comprehensive treatment of ovarian, cervical, endometrial, vulvar, and vaginal cancers, with particular expertise in advanced and recurrent disease. Dr. Sekhon's clinical depth is anchored in complex surgical oncology techniques including cytoreductive surgery with HIPEC (hyperthermic intraperitoneal chemotherapy) and PIPAC (pressurised intraperitoneal aerosol chemotherapy) for recurrent ovarian cancer. Her adoption of robotic gynaecologic oncology has enabled greater surgical precision, reduced patient recovery times, and improved long-term outcomes. She has performed a significant volume of complex cancer surgeries and has been instrumental in developing advanced oncology programs across leading institutions. Her additional interests encompass cervical cancer screening, pre-invasive lesion management, and fertility-sparing approaches to cancer treatment—a critical consideration for younger women facing a cancer diagnosis. International patients from the Gulf region, Africa, and South Asia benefit from Dr. Sekhon's multi-lingual capabilities (English, Hindi, and Tamil) and her extensive experience managing patients across cultural and geographic boundaries. Her patient-centred approach combines surgical expertise with compassionate care, ensuring that women undergoing complex cancer treatment receive both clinical excellence and emotional support throughout their journey. Dr. Sekhon practices at Apollo Athenaa Women's Cancer Centre in Chennai, a dedicated facility specialising exclusively in women's oncology. The centre is equipped with state-of-the-art diagnostic and surgical technology, including robotic platforms, advanced imaging, and dedicated oncology beds. Apollo's commitment to international patient support, multilingual staff, and integrated care pathways makes it an ideal destination for women seeking expert gynaecologic cancer care. The hospital maintains NABH accreditation and comprehensive infrastructure for both primary and tertiary cancer management. International patients choosing Dr. Sekhon can expect thorough pre-treatment assessment, detailed treatment planning, and seamless coordination of their entire care episode. Gaf Healthcare facilitates easy booking, pre-consultation document review, and ongoing follow-up—ensuring that women from abroad receive the same quality and continuity of care as those treated locally.

Dr. Harit Kumar Chaturvedi is Chief Executive Officer and Clinical Head of Surgical Oncology at Indraprastha Apollo Hospital in New Delhi, bringing over 32 years of dedicated experience to the field of cancer surgery. He holds an M.Ch in Surgical Oncology from AIIMS New Delhi and completed his fellowship at Tata Memorial Hospital, Mumbai—credentials that establish him as one of India's most respected surgical oncologists. His clinical journey has been defined by a commitment to precision, innovation, and comprehensive cancer care across multiple organ systems. Dr. Chaturvedi's clinical portfolio spans the full spectrum of surgical oncology, including breast cancer, head and neck malignancies, lung, gastric, colorectal, pancreatic, renal, bladder, and esophageal cancers. He is a pioneer in robotic-assisted surgical oncology across South Asia, proficient in the da Vinci Xi robotic systems, and performs advanced procedures including cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). His high-volume practice and mastery of both open and minimally invasive techniques enable him to offer individualized treatment plans tailored to each patient's cancer stage and overall health. International patients form a significant part of Dr. Chaturvedi's practice. He regularly treats patients from the Middle East, SAARC nations, CIS countries, and Africa, offering them access to world-class cancer care with the reassurance of fluent English communication, transparent treatment planning, and a patient-centric approach. Many international patients value his shared decision-making model, which ensures clarity at every stage of care and empowers patients to participate actively in their treatment journey. Indraprastha Apollo Hospital, where Dr. Chaturvedi leads the surgical oncology division, is a NABH and JCI-accredited institution equipped with state-of-the-art robotic surgical suites, advanced imaging, and dedicated intensive care facilities. The hospital's international patient services team facilitates visa assistance, accommodation coordination, and seamless follow-up care, making it an ideal destination for overseas patients seeking complex cancer surgery. Dr. Chaturvedi's leadership and his hospital's infrastructure combine to offer international patients the confidence that they are receiving treatment at par with leading global oncology centers. For patients seeking a surgical oncologist with deep expertise, international exposure, and a genuine commitment to shared decision-making, Dr. Chaturvedi represents the caliber of care that has established India as a leading destination for cancer surgery. His 32+ years of experience, combined with his mastery of cutting-edge surgical techniques and his recognition within major Indian and international oncology societies, ensure that international patients receive evidence-based, compassionate care aligned with global best practices.

Dr. Amita Mahajan is a Senior Consultant in Pediatric Hematology and Oncology at Indraprastha Apollo Hospital, New Delhi, with over 32 years of dedicated clinical experience in childhood blood disorders and cancers. She completed her MBBS and MD in Pediatrics from the All India Institute of Medical Sciences (AIIMS), New Delhi, followed by advanced international training: the MRCPCH from the Royal College of Paediatrics and Child Health, London, and specialist training (CCST) in Pediatric Oncology in the United Kingdom. This globally informed foundation enables her to deliver care aligned with the highest international standards. Dr. Mahajan's clinical expertise spans the full spectrum of pediatric hematology and oncology, including pediatric bone marrow transplantation, acute and chronic leukemias, thalassemia, sickle cell disease, aplastic anemia, hemophilia, and other complex blood disorders. She brings a multidisciplinary, evidence-based approach to each patient, ensuring comprehensive and compassionate management from diagnosis through long-term follow-up. International families seeking expert care for their children have consistently chosen Dr. Mahajan. She routinely treats patients from the Gulf region, Africa, and the broader South Asian community, providing culturally sensitive care and clear communication in English and Hindi. Her advisory roles with leading patient advocacy organizations—including CanKids, Leukemia Crusaders, and Thalassemics India—further demonstrate her commitment to supporting families navigating these serious conditions. At Indraprastha Apollo Hospital and Apollo Cancer Centre, Dr. Mahajan operates within a state-of-the-art environment equipped with advanced diagnostic and therapeutic facilities, including specialized oncology wards, ICU support, and modern imaging capabilities. The hospital's strong international patient support infrastructure, NABH accreditation, and access to tertiary-level pediatric services ensure families receive seamless, coordinated care. For families traveling internationally to secure expert pediatric oncology and hematology care, Dr. Mahajan offers decades of subspecialty experience combined with a proven track record of managing the most complex cases. Her position as an Executive Member of the Indian Pediatric Oncology Group further underscores her standing within the specialty.

Dr. Parinitha Reddy Gutha is the Clinical Director and Head of Department of Paediatric Oncology & Haematology at Yashoda Hospitals in Hyderabad. She holds the prestigious FRCPCH qualification from the Royal College of Paediatrics and Child Health, London, and brings over 26 years of comprehensive clinical expertise in diagnosing and treating childhood cancers, blood disorders, and performing paediatric bone marrow transplantation. Her training spans leading international institutions, including a clinical fellowship in paediatric oncology at the Royal Marsden Hospital in London and advanced roles at Great Ormond Street Hospital for Children and Leicester Royal Infirmary, equipping her with internationally recognized expertise. Dr. Parinitha specializes in a broad spectrum of paediatric haematology and oncology conditions, including paediatric leukemia, thalassemia, sickle cell disease, aplastic anemia, and complex bone marrow disorders. She has established and led the Department of Paediatric Oncology & Haematology at the American Oncology Institute, Citizens Hospital, demonstrating her exceptional leadership in building specialized paediatric care programs. Her clinical work encompasses diagnostic evaluation, chemotherapy management, supportive care, and bone marrow transplantation, with a particular focus on evidence-based treatment protocols and outcomes optimization. Dr. Parinitha has developed a strong international patient practice, regularly treating families from the Gulf region, North Africa, and the broader South Asian diaspora. She is fluent in English, Hindi, and Telugu, and her compassionate, child-centred approach has made her a trusted choice for international families seeking expert paediatric oncology and haematology care. She dedicates her practice to children and adolescents up to 18 years of age, ensuring age-appropriate, family-inclusive care planning. Yashoda Hospitals is a NABH-accredited multispecialty facility in Hyderabad with advanced paediatric intensive care units, dedicated oncology wards, and bone marrow transplantation facilities. The hospital has established itself as a regional destination for complex paediatric cases, combining cutting-edge diagnostic imaging with experienced nursing and supportive care teams. For international patients, Yashoda offers dedicated medical tourism support, including pre-arrival consultation, visa assistance, and coordinated follow-up care. Patients from across the Gulf, Africa, and Central Asia appreciate the hospital's blend of world-class infrastructure, experienced specialist teams, and cost-effective treatment in a culturally welcoming environment.

Dr. Vinay Samuel Gaikwad is a dynamic and extensively trained surgical oncologist and Robotic & Laparoscopic GI surgeon at Fortis Hospital, Manesar, Gurugram. With over 24 years of rich clinical experience, he has been associated with some of the top hospitals in India, including Tata Memorial Hospital, Mumbai and MSKCC, New York. He completed his Fellowship in GI & HPB Surgical Oncology from Tata Memorial Hospital and his Hepatopancreatobiliary Oncology Training from MSKCC, New York. Dr. Gaikwad is proficient in performing the most advanced cancer surgeries including HIPEC and PIPAC, and has authored several articles for both national and international publications. He also specialises in GI and HPB Surgical Oncology and Peritoneal Surface Oncology. He presently leads a team of organ-based surgical oncologists and has been the first to start a hepatic artery infusion pump chemotherapy programme in India — a pioneering achievement that offers patients with liver-dominant metastatic colorectal cancer a powerful additional treatment option. Dr. Gaikwad is certified in HIPEC from ESSO Hannover, Germany and PIPAC from Tubingen, Germany, and has received training in minimally invasive colorectal surgery from AETF South Korea and upper GI surgery from IRCAD Taiwan. He has been recognised with the Most Trusted Oncologist Award 2023 by ASIA-GCC and the Blackswan Award for Excellence in Healthcare 2023-24 by Asia One.

Dr. Shishir Seth is a highly experienced Consultant in Hemato-Oncology and Bone Marrow Transplant at the Apollo Cancer Institute, Indraprastha Apollo Hospital, New Delhi. With over 24 years of clinical practice, he has earned a reputation as a trusted specialist for patients with complex blood disorders and hematologic malignancies seeking advanced transplant care. His comprehensive qualifications include an MD in Medicine, a DM in Clinical Hematology from Mumbai, and a prestigious Fellowship in Leukemia and Blood and Marrow Transplant from the Division of Hematology at Vancouver General Hospital, Canada—training that uniquely positions him to handle the most challenging cases. Dr. Seth's clinical expertise spans a broad spectrum of hemato-oncologic conditions and transplant procedures. He specializes in bone marrow transplantation in all its forms—allogeneic, autologous, matched sibling donor, matched unrelated donor, and haploidentical approaches—as well as the management of acute leukemias, myelodysplastic syndromes, lymphomas, and bone marrow failure disorders. His evidence-based approach and meticulous patient selection ensure optimal outcomes even in complex and high-risk scenarios. His ongoing involvement in clinical research and investigator-initiated studies reflects a commitment to advancing the field of hematology and transplant medicine. Dr. Seth has developed a strong track record treating international patients from the Gulf, Africa, and South Asia. His fluency in English and Hindi, combined with his experience managing diverse patient populations, ensures that patients from across borders receive culturally sensitive, comprehensive care. International patients appreciate his clear communication and his ability to coordinate complex pre-transplant evaluation and long-term post-transplant follow-up across continents. Indraprastha Apollo Hospital stands as one of India's premier tertiary-care institutions, equipped with state-of-the-art hematology and transplant facilities, dedicated ICU capacity, and a robust international patient support team. The hospital's NABH and JCI accreditations reflect its commitment to world-class clinical governance. Dr. Seth's base at this institution provides international patients access to high-volume, specialized care in a setting designed for seamless coordination and continuity of treatment. International patients considering bone marrow transplantation or complex hematologic treatment should know that Dr. Seth combines deep technical expertise with a patient-first philosophy. Gaf Healthcare can coordinate all aspects of your journey—from initial consultation and investigations to in-hospital care and long-term follow-up—ensuring a smooth, transparent experience from India.

Dr. Manish Jain is a distinguished Surgical Oncologist and Director & Unit Head of Gastrointestinal Oncosurgery at BLK-Max Super Speciality Hospital in New Delhi, India. With over 20 years of extensive clinical and surgical experience, Dr. Jain has established himself as a leading expert in the surgical management of gastrointestinal cancers. He holds qualifications including MBBS, MS in General Surgery, and DrNB in Surgical Gastroenterology, alongside certifications as a robotic surgeon and PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) specialist. Dr. Jain specializes in the comprehensive surgical care of cancers affecting the esophagus, stomach, pancreas, gallbladder, bile ducts, liver, and colorectal organs. His proficiency spans both open and minimally invasive oncologic approaches, including robotic surgery using the Intuitive Da Vinci X and Xi platforms, as well as complex procedures such as cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) for peritoneal surface malignancies. His technical expertise and strategic case management have made him a trusted name in gastrointestinal and hepatopancreatobiliary (HPB) oncosurgery across India. Dr. Jain is deeply committed to delivering personalized care to international patients seeking treatment in India. His hospital, BLK-Max, attracts patients from the Gulf Cooperation Council region, Africa, and South Asian countries seeking advanced oncologic surgery at competitive costs. He works closely with Gaf Healthcare to facilitate seamless consultations via video conferencing and WhatsApp for international patients, ensuring comprehensive pre-operative assessments and treatment planning regardless of geography. BLK-Max Super Speciality Hospital is recognized for its state-of-the-art surgical facilities, dedicated cancer center, and international patient services. The hospital maintains NABH accreditation and offers comprehensive ICU support, advanced imaging, and multidisciplinary tumor boards that ensure every oncology case receives collaborative expert review. For international patients, BLK-Max provides dedicated medical coordinators, translation services, and seamless logistics support to make treatment in New Delhi accessible and convenient. Dr. Jain is an active member of the Indian Association of Surgical Oncology, the International Hepato-Pancreato-Biliary Association, the Association of Surgeons of India, and the Association of Minimal Access Surgeons of India. His professional engagement reflects his commitment to evidence-based practice and continuous advancement in surgical oncology. International patients can expect world-standard oncologic surgery combined with the cost-effectiveness that makes New Delhi a preferred destination for complex gastrointestinal cancer treatment.

Dr. Sanjeev Kumar Sharma is the Director of Haemato-oncology and Bone Marrow Transplant at BLK-Max Super Speciality Hospital in New Delhi, one of India's leading tertiary-care centers. With over 20 years of clinical experience, he is widely recognized for his expertise in hematologic malignancies and complex bone marrow disorders. His career has been built on a foundation of rigorous training in clinical hematology and a deep commitment to evidence-based care, evidenced by his DM qualification and memberships in the Indian Society of Hematology and Blood Transfusion. Dr. Sharma's clinical practice encompasses the entire spectrum of bone marrow transplantation—autologous, allogeneic, haploidentical donor, and matched sibling and unrelated donor transplants. He is equally accomplished in managing acute leukemias, myelodysplastic syndromes, lymphomas, and bone marrow failure syndromes. His approach integrates reduced-intensity conditioning protocols and peripheral blood stem cell transplants to optimize outcomes while minimizing treatment burden. The breadth of his procedural repertoire and high case volumes position him as a trusted authority among peers and patients alike. International patients form a significant part of Dr. Sharma's practice, with patients traveling from the Gulf states, Africa, and across South Asia for consultation and treatment. He is known for his patient-centric philosophy, taking time to explain complex diagnoses and treatment options in clear language. His multilingual capability (English and Hindi) and familiarity with international patient protocols ensure a seamless experience for overseas visitors. Many families appreciate his compassionate yet direct communication style when discussing prognosis and individualized treatment plans. BLK-Max Super Speciality Hospital, where Dr. Sharma leads the Centre for Bone Marrow Transplant, is a NABH-accredited, multi-specialty facility with state-of-the-art oncology and hematology departments. The hospital houses dedicated BMT units with advanced isolators, comprehensive ICU support, and a robust international patient services desk. New Delhi's accessibility via multiple international airports and the availability of quality hotels and support services make it an ideal destination for complex hematological care. Patients under Dr. Sharma's care benefit not only from his clinical expertise but also from the hospital's integrated supportive care infrastructure, making it possible to manage even highly complex transplant scenarios with confidence.

Dr. Keshavarajan G is a Consultant Surgical Oncologist at Rela Hospital's Cancer Centre in Chennai, bringing 17+ years of clinical experience to the field of cancer surgery. He holds an MCh in Surgical Oncology from the Regional Cancer Centre, Thiruvananthapuram—one of India's leading cancer treatment institutions—complemented by an MS in General Surgery from Madras Medical College and an MBBS from JSS Medical College, Mysore. His comprehensive training positions him as a trusted surgeon for complex oncological cases across multiple cancer types. Dr. Keshavarajan specializes in a broad spectrum of surgical oncology procedures, including breast cancer and oncoplastic breast surgery, gynecological malignancies, colorectal and gastric cancer resections, esophageal and head-and-neck tumor surgery, and advanced techniques such as sentinel lymph node biopsy, cytoreductive surgery with HIPEC, and limb salvage operations. He is certified in PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) and is committed to minimally invasive surgical approaches wherever clinically appropriate. His practice reflects a multidisciplinary philosophy, integrating surgical expertise with attention to post-operative rehabilitation and long-term cancer survivorship. International patients—particularly from the Gulf region, Africa, and South Asia—benefit from his experience managing complex cases and his fluency in English, Hindi, and Tamil. He collaborates seamlessly with multidisciplinary cancer teams to ensure coordinated care before, during, and after surgery. His academic contributions include indexed and non-indexed publications and presentations at both national and international forums, reflecting his engagement with evolving surgical oncology literature and best practices. Rela Hospital, where Dr. Keshavarajan practices, is a state-of-the-art tertiary care center renowned for its comprehensive cancer services, advanced diagnostic imaging, and dedicated oncology units. The hospital's infrastructure, combined with Dr. Keshavarajan's surgical precision and patient-centered approach, makes it an ideal destination for international patients seeking specialized cancer surgery. International patients should know that Rela Hospital has an established international patient services desk, transparent pricing, and a reputation for managing complex cases with compassionate follow-up care across borders.

Dr. Archit Pandit is Director of Surgical Oncology at Fortis Escorts, Okhla Road, New Delhi and is a highly accomplished and skilled surgical oncologist trained at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. With over 15 years of clinical excellence, he has the distinction of performing more than 10,000 complex surgeries during his career spanning about a decade and a half. Internationally trained, Dr. Pandit has completed fellowships at the National Cancer Center, Tokyo (Japan) in minimally invasive gastroesophageal surgeries, and at Yonsei University Severance Hospital, Seoul (South Korea) in thoracic surgery and lung transplantation. He is also trained in Robotic Surgery at the Galaxy Care Institute, Pune, and underwent Colorectal Cancer Training with the Asian Endoscopic Task Force in Fuji, Japan. Additionally, he has completed courses in Advanced Laparoscopy and Pain & Palliative Medicine at AIIMS, New Delhi. Dr. Pandit has various publications in reputed international & national journals. Dr. Archit Pandit is a Gold Medalist (Best Outgoing MS Surgery, Karnataka, 2008) and has won Best Video Awards at the Indian Cancer Congress (2013) and ACOS (2016).

Dr. Dhwanee Thakkar is a Consultant in Pediatric Hematology and Oncology at Medanta - The Medicity in Gurugram, India. With over 14 years of dedicated clinical experience, she brings specialized expertise in diagnosing and managing complex hematological disorders in children. Her academic credentials include an MD in Pediatrics from VNSGU (2012), a Fellowship in Pediatric Hematology Oncology from the National Board of India, and an IAP Fellowship in Pediatric Hematology Oncology and Bone Marrow Transplant. Her international training includes a prestigious Fellowship in Haemostasis and Thrombosis at The Royal Infirmary of Edinburgh, Scotland (2017), which reflects her commitment to world-standard clinical practice. Dr. Thakkar's clinical expertise spans the full spectrum of pediatric hematological conditions, including leukemias, lymphomas, aplastic anemia, thalassemia, and sickle cell disease. She is particularly skilled in managing rare bleeding disorders, hemophilia, coagulation disorders, and primary immunodeficiencies. Her hands-on experience in Hematopoietic Stem Cell Transplantation and chemotherapy administration for pediatric malignancies demonstrates her capability to manage both routine and complex cases. Her special interest in hemophilia and rare bleeding disorders, combined with her academic recognition including gold medals for her MD postgraduate training, underscores her commitment to evidence-based pediatric care. International families seeking specialized pediatric hematology care benefit from Dr. Thakkar's experience treating patients from across India and abroad. She is fluent in English and Hindi, and works closely with Gaf Healthcare to facilitate seamless consultations for patients from the Gulf, Africa, and SAARC regions. Her patient-centered approach ensures that complex diagnoses are explained clearly to families, and treatment plans are tailored to each child's clinical and emotional needs. Medanta - The Medicity in Gurugram is a leading multispecialty tertiary care hospital, renowned for its comprehensive pediatric services and state-of-the-art facilities. The hospital houses dedicated pediatric oncology and hematology units with advanced diagnostic and therapeutic infrastructure, including bone marrow transplant capabilities. Accreditation and international clinical protocols ensure families receive care aligned with global standards. The hospital's international patient services team supports visa arrangements, accommodation, and coordination with Gaf Healthcare. International patients choosing Dr. Thakkar benefit from India's reputation for affordable, high-quality pediatric care. Initial consultations can be conducted virtually via video call, allowing families to discuss their child's condition and treatment options before travel. Medical records and diagnostic imaging are reviewed promptly, and second-opinion services are available for complex cases.

Dr. Manish Gaur is the Principal Consultant of Surgical Oncology at Max Super Speciality Hospital, Saket and Max Smart Super Speciality Hospital, Saket, New Delhi. He brings substantial training and experience in surgical oncology from premier Indian institutions, including AIIMS, New Delhi. After completing his MBBS at Kilpauk Medical College, Chennai (2011), Dr. Gaur went on to complete his MS in General Surgery at University College of Medical Sciences, New Delhi (2017), and his MCh in Surgical Oncology at All India Institute of Medical Sciences (AIIMS), New Delhi (2019). He further pursued international training including a Travelling Fellowship in INDO-UK Breast Oncoplasty (2025) and a Certificate Course (PIPAC) in Pleura and Peritoneum from the International Society for the Study of Pleura and Peritoneum (ISSPP) and the Indian Society of Peritoneal Surface Malignancies in Bengaluru (2024). Dr. Gaur's clinical expertise spans head and neck cancer surgery, breast cancer surgery (including breast conservation and oncoplastic/reconstructive procedures), thyroid and salivary gland tumour surgery, sentinel node biopsy, oncoplastic and reconstructive oncology, hyperthermic intraperitoneal chemotherapy (HIPEC), electrochemotherapy, and minimally invasive and precision oncology surgery.

Dr. Viruvanti Dinesh is a Consultant Pediatric Hematologist and Oncologist at Yashoda Hospitals, Secunderabad, in Hyderabad, India. With over 12 years of clinical experience, he has dedicated his career to diagnosing and treating complex blood disorders and cancers in children. His specialization encompasses a broad range of pediatric hematologic and oncologic conditions, bringing both technical expertise and compassionate care to young patients and their families. Dr. Dinesh completed his prestigious FNB (Fellowship of National Board) in Pediatric Hematology-Oncology from the Basavatarakam Indo-American Cancer Hospital and Research Institute in Hyderabad, one of India's leading cancer centers. His clinical training included comprehensive exposure to pediatric leukemia management, bone marrow transplantation, aplastic anemia treatment, and complex methotrexate clearance protocols. He has presented research at major national conferences, including work on microbiological profiles in febrile neutropenia and management strategies for extreme hyperleukocytosis in acute lymphoblastic leukemia. His MD in Pediatrics from Vardhman Mahavir Medical College and MBBS from SDM College provide a solid foundation in general pediatric care, which he integrates into his oncology practice. Dr. Dinesh treats patients from across the Gulf region, Africa, and the Indian subcontinent, offering multilingual support in English, Hindi, and Telugu. He is committed to providing evidence-based care and maintaining international standards in pediatric oncology. Patients report high satisfaction with his thorough diagnostic approach and clear communication, even across language and cultural boundaries. Yashoda Hospitals, Secunderabad, where Dr. Dinesh practices, is a NABH-accredited multi-specialty center equipped with advanced pediatric ICU facilities, modern imaging, and dedicated oncology wards. The hospital maintains robust international patient services, including visa assistance and accommodation coordination, making it an accessible destination for families seeking specialized pediatric cancer care. The institution's comprehensive support infrastructure ensures that international families receive not only world-class medical treatment but also the logistical support needed during complex pediatric treatments. For international patients considering pediatric hematology-oncology consultation in India, Dr. Dinesh offers a unique combination of subspecialty training at a premier cancer hospital, active engagement with international professional bodies, and a proven track record with cross-border patient care. His membership in SIOP (Société Internationale d'Oncologie Pédiatrique) and the Indian Academy of Pediatrics ensures he remains current with global best practices in childhood cancer management.

Dr. Prerana Nesargi is a Consultant in Paediatric Oncology, Hematology, and Bone Marrow Transplant at Gleneagles Hospitals in Bengaluru, bringing over 11 years of dedicated clinical experience in the specialized care of children with cancer and blood disorders. She holds an MBBS degree followed by an MD in Paediatrics and a DM in Paediatric Oncology, qualifications that underscore her rigorous training and deep expertise in the field. Dr. Prerana's clinical practice encompasses a comprehensive range of pediatric hematologic and oncologic conditions, including acute leukemia, lymphoma, multiple myeloma, and bone marrow disorders such as aplastic anemia and thalassemia. She is particularly skilled in pediatric bone marrow transplantation and chemotherapy protocols, managing complex cases with both medical precision and an intimate understanding of pediatric physiology. Her approach combines evidence-based treatment strategies with meticulous monitoring to achieve optimal outcomes while minimizing treatment-related complications in young patients. Known for her compassionate and patient-centered approach, Dr. Prerana regularly treats international patients from the Gulf, East Africa, and South Asia who seek specialized pediatric oncology care in India. She is fluent in English, Hindi, and Kannada, ensuring clear communication with diverse families. Her practice prioritizes not only medical recovery but also the emotional and psychological well-being of each child and family throughout the treatment journey, making her a trusted consultant for families navigating complex pediatric cancer diagnoses. Dr. Prerana practices at Gleneagles Hospitals, Bengaluru, a multi-specialty facility known for its advanced oncology infrastructure, experienced support team, and family-oriented care model. The hospital's commitment to pediatric excellence, combined with state-of-the-art diagnostic and therapeutic capabilities, makes it an ideal destination for families seeking world-standard cancer care for their children. International patients benefit from dedicated support services, English-speaking staff, and streamlined admission processes that facilitate seamless treatment experiences.

Dr. Richa Ashok Bansal is a Consultant in Surgical Oncology at Apollo Hospitals, Mumbai, and a specialist in gynecologic cancer surgery with over 10 years of clinical experience. She holds an MCh in Gynaecological Oncology from the prestigious Tata Memorial Hospital, coupled with an MS in General Surgery and DNB qualification in Surgical Oncology. Her fellowship with the European Society of Gynaecological Oncology (ESGO) positions her at the forefront of international oncologic surgical standards. Dr. Bansal's clinical expertise spans the full breadth of gynecologic malignancies, including cervical, ovarian, endometrial, vulvar, and vaginal cancers. She is particularly skilled in complex procedures such as cytoreductive surgery for advanced ovarian cancer, radical hysterectomy, sentinel lymph node biopsy, and lymphadenectomy in gynecologic cancers. Her approach combines meticulous surgical technique with comprehensive patient assessment to optimize outcomes in both early-stage and advanced disease. Dr. Bansal is experienced in treating patients from across the Gulf, Africa, and South Asia who seek specialist gynecologic cancer care in India. She communicates fluently in English and Hindi, ensuring clarity and reassurance throughout the treatment journey. Her patient-centered philosophy integrates surgical intervention with non-surgical modalities, offering holistic oncologic management that addresses both physical and emotional aspects of care. Apollo Hospitals Mumbai is a leading tertiary-care center with JCI accreditation, state-of-the-art surgical suites, and a dedicated oncology department. The hospital's comprehensive tumor board, advanced imaging, and access to multimodal treatments make it an ideal destination for international patients seeking complex gynecologic cancer surgery. Apollo's robust international patient services, including visa assistance and arranged accommodation, ease the logistics of medical travel. International patients choosing Dr. Bansal benefit from India's cost-effective healthcare, world-standard surgical facilities, and the opportunity for follow-up care coordination with their home physicians—all essential factors in complex cancer management.

Dr. Aiswarya Sekar is a Gynecologic Oncosurgeon with specialized expertise in the surgical management of complex gynecologic malignancies. She completed her Master of Chirurgiae (MCh) in Gynecologic Oncology from Tata Memorial Hospital, Mumbai — India's premier cancer institute — where she received rigorous training in advanced oncologic surgery and multidisciplinary cancer care protocols. Dr. Sekar brings deep clinical proficiency across the full spectrum of gynecologic cancers. Her surgical repertoire includes cytoreductive surgery for advanced ovarian cancer, HIPEC (Heated Intraperitoneal Chemotherapy), radical hysterectomy for cervical and endometrial cancers, vulvar cancer management, and minimally invasive robotic-assisted procedures. She is particularly known for her thoughtful approach to fertility-preserving oncologic surgery, allowing women with cancer to undergo oncologically safe treatment while maintaining reproductive potential where feasible. She has contributed to clinical research and participated in national and international forums in gynecologic oncology. Dr. Sekar is well-experienced in treating international patients, including those from the Gulf region, East Africa, and South Asia. She maintains a patient-centered, evidence-based approach and is skilled in managing complex cases, including hereditary cancer syndromes and cases requiring multidisciplinary input. Her practice emphasizes clear communication, tailored treatment planning, and compassionate support throughout the patient journey. Based at Dr. Rela Institute & Medical Centre in Chennai, one of India's leading multi-specialty cancer centers, Dr. Sekar benefits from state-of-the-art operating theaters, advanced imaging and pathology services, and a strong infrastructure for both inpatient and outpatient oncologic care. The institute is recognized for its international patient services and comprehensive cancer programs. International patients choosing Dr. Sekar can expect thorough consultation, clear surgical planning, coordinated follow-up care, and seamless support in English and regional languages throughout their treatment.